Search research articles
Contact Us
Filters
Showing results (81-90 of 165) with videos related to
Page
of 17
Sort By:
European Journal of Haematology
|
January 5, 2011
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells
Cesarina Giallongo, Piera La Cava, Daniele Tibullo, et al.
Journal of Cellular and Molecular Medicine
|
December 9, 2017
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib
Cesarina Giallongo, Nunziatina L Parrinello, Piera La Cava, et al.
Plos One
|
July 9, 2016
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients
Cesarina Giallongo, Alessandra Romano, Nunziatina Laura Parrinello, et al.
Experimental Hematology
|
February 24, 2015
Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftment
Giuseppe Milone, Maria Grazia Camuglia, Giuseppe Avola, et al.
Annals of Hematology
|
April 17, 2024
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey
Andrea Duminuco, Alessandra Romano, Isacco Ferrarini, et al.
Cancers
|
August 26, 2023
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study
Vittorio Del Fabro, Mary Ann Di Giorgio, Valerio Leotta, et al.
Frontiers in Immunology
|
October 9, 2023
Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience
Andrea Duminuco, Uros Markovic, Nunziatina Laura Parrinello, et al.
Current Neuropharmacology
|
July 7, 2025
In vivo Effects of Disease-modifying Therapies on Immunological Subsets in Patients with Relapsing-Remitting Multiple Sclerosis
Chiara Finocchiaro, Clara Grazia Chisari, Salvatore Lo Fermo, et al.
Journal of Hematology & Oncology
|
March 18, 2016
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma
Giorgio La Nasa, Marianna Greco, Roberto Littera, et al.
Leukemia Research
|
November 5, 2013
CD200 expression in patients with Multiple Myeloma: another piece of the puzzle
Concetta Conticello, Raffaella Giuffrida, Nunziatina Parrinello, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 165) with videos related to
Sort By:
Page
of 17
European Journal of Haematology
|
January 5, 2011
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells
Cesarina Giallongo, Piera La Cava, Daniele Tibullo, et al.
Journal of Cellular and Molecular Medicine
|
December 9, 2017
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib
Cesarina Giallongo, Nunziatina L Parrinello, Piera La Cava, et al.
Plos One
|
July 9, 2016
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients
Cesarina Giallongo, Alessandra Romano, Nunziatina Laura Parrinello, et al.
Experimental Hematology
|
February 24, 2015
Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftment
Giuseppe Milone, Maria Grazia Camuglia, Giuseppe Avola, et al.
Annals of Hematology
|
April 17, 2024
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey
Andrea Duminuco, Alessandra Romano, Isacco Ferrarini, et al.
Cancers
|
August 26, 2023
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study
Vittorio Del Fabro, Mary Ann Di Giorgio, Valerio Leotta, et al.
Frontiers in Immunology
|
October 9, 2023
Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience
Andrea Duminuco, Uros Markovic, Nunziatina Laura Parrinello, et al.
Current Neuropharmacology
|
July 7, 2025
In vivo Effects of Disease-modifying Therapies on Immunological Subsets in Patients with Relapsing-Remitting Multiple Sclerosis
Chiara Finocchiaro, Clara Grazia Chisari, Salvatore Lo Fermo, et al.
Journal of Hematology & Oncology
|
March 18, 2016
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma
Giorgio La Nasa, Marianna Greco, Roberto Littera, et al.
Leukemia Research
|
November 5, 2013
CD200 expression in patients with Multiple Myeloma: another piece of the puzzle
Concetta Conticello, Raffaella Giuffrida, Nunziatina Parrinello, et al.
Page
of 17